Valiant Laboratories Limited (BOM:543998)
95.71
+4.24 (4.64%)
At close: Aug 21, 2026
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 5.2 billion as of August 21, 2026. Its market cap has increased by 8.73% in one year.
Market Cap
5.20B
Enterprise Value
5.33B
Revenue
3.06B
Ranking
n/a
PE Ratio
32.47
Stock Price
95.71
ChartMarket Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 5.20B, a decrease of -29.71%. That is a compound annual growth rate of -11.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 5.20B | 36.77% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hexagon Nutrition | 8.48B |
| Anuh Pharma | 7.62B |
| ZIM Laboratories | 6.30B |
| Kilitch Drugs (India) | 5.58B |
| Albert David | 4.77B |
| Jenburkt Pharmaceuticals | 4.64B |
| Ambalal Sarabhai Enterprises | 3.66B |
| Medico Remedies | 3.55B |